Patent ID: 11866446
Assignee: VERTEX PHARMACEUTICALS INCORPORATED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 16:
17. The compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt according to claim 1, wherein R1 is selected from hydrogen, halogen, cyano,, —OH, C1-C4 alkyl, C1-C4 alkoxy, and C3-C6 cycloalkyl; wherein:
the C1-C4 alkyl of R1 is optionally substituted with 1 to 3 groups independently selected from halogen, cyano, —OH, and C1-C2 alkoxy;
the C1-C4 alkoxy of R1 is optionally substituted with 1 to 3 independently selected halogen groups; and
the C3-C6 cycloalkyl of R1 is optionally substituted with 1 to 3 groups independently selected from halogen, cyano, —OH, and C1-C2 alkoxy.